Product Information
MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $24.8668 per ML under NDC 00548541025. Its NADAC has been published 210 times since Oct 2, 2019.
FDA first approved this application on Nov 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548541025
Classification
Generic
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
4/23/2025
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077235FDA Approved
11/28/2017
TE Code
AB
On Market Since
11/28/2017
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 210 times since Oct 2, 2019, and over the history we have for it it has declined 41.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.8668 per ML |
|---|---|
| All-time high | $42.7013 (Oct 16, 2019) |
| All-time low | $21.9454 (Aug 18, 2021) |
| Median price | $30.7723 |
| Average price | $32.7433 |
| Largest weekly change | +40.2% (Sep 22, 2021) |
| Weeks tracked | 210 |
| Tracking since | Oct 2, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-19.2%
5Y
+13.3%
All
-41.8%
Last surveyed Apr 30, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Amphastar Pharmaceuticals, Inc., is $24.8668 per ML (NDC 00548541025), effective Apr 30, 2025.
How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 41.8%. It has been tracked across 210 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?
Since Oct 2, 2019, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $21.9454 (Aug 18, 2021) to a high of $42.7013 (Oct 16, 2019), with a median of $30.7723 per ML.
Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.3134 per ML — about 26% below MEDROXYPROGESTERONE 150 MG/ML.
Who manufactures MEDROXYPROGESTERONE 150 MG/ML?
MEDROXYPROGESTERONE 150 MG/ML (NDC 00548541025) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.